← Back to headlines
McKesson acquires precision medicine company
McKesson is investing an additional $2.25 billion into its oncology division through the acquisition of a precision medicine firm.
6 Sept, 20:43 — 6 Sept, 20:43
Sources
Showing 1 of 1 sources
